Bot Detector
IJPC Seal
Download FREE Sample Issue or Article
LEARN MORE
Subscribe Today
A subscription to IJPC provides on-line access to full-text, full-color, printable PDF copies of all issues and individual articles published by the Journal since 1997.

Library Archives
Volume 12, 2008 Archive

Six issues from 2008 in one convenient archive.

This archive contains the following articles listed by volume, issue and page number:

Issues Included
Issue/Volume Title
January/February 2008
Vol. 12 No. 1
Compounding for Hospice and Cancer Patients
March/April 2008
Vol. 12 No. 2
Compounding Around the World
May/June 2008
Vol. 12 No. 3
Pain Management
July/August 2008
Vol. 12 No. 4
Hormone Replacement Therapy
September/October 2008
Vol. 12 No. 5
Veterinary Compounding
November/December 2008
Vol. 12 No. 6
Arthritis and Immunological Diseases

Volume 12, 2008 Articles
Title/Author
(Click for Abstract / Details / Purchase)
Issue/​Page
View/Buy
PreScription: Year Number 12…And Still Much Work to Do
Allen Loyd V Jr
Jan/Feb 2008
Pg. 4

Intravitreal Bevacizumab for Choroidal Neovascularization in Age-Related Macular Degeneration
Dib Jean G
, Abdulmohsin Saud
Jan/Feb 2008
Pg. 8-14

Cancer-Related Terminology: Glossaries for Compounding Pharmacists and Their Clients
Williams LaVonn A
Jan/Feb 2008
Pg. 16-27

Hospice and Compounding Pharmacy: Once Inseperable
Williams LaVonn A
Jan/Feb 2008
Pg. 28-37

Disposing of Expired Drugs and Chemicals: New Options for Compounders
Vail Jane
Jan/Feb 2008
Pg. 38-47

View Sample
Websites: Keeping Current in 2008
Storey Patricia L
Jan/Feb 2008
Pg. 48-49

Quality-Control Analytical Methods: Stability Versus Potency Testing: The Madness is in the Method
Kupiec Thomas C
, Skinner Rodney, Lanier Lance
Jan/Feb 2008
Pg. 50-53

Calculations: Compounding for Cancer Patients
Stockton Shelly J
Jan/Feb 2008
Pg. 62

Standard Operating Procedure: Compliance with the Health Insurance Portability and Accountability Act (HIPAA) of 1996
Allen Loyd V Jr
Jan/Feb 2008
Pg. 63

Cyclosporine Topical Gel
Allen Loyd V Jr
Jan/Feb 2008
Pg. 64

Diclofenac Sodium 1% Soft-Patch Gel
Allen Loyd V Jr
Jan/Feb 2008
Pg. 65

Diclofenac Sodium 1% Soft-Patch Lipophilic Gel
Allen Loyd V Jr
Jan/Feb 2008
Pg. 66

Basics of Compounding: Considerations for Implementing United States Pharmacopeia Chapter <797> Pharmaceutical Compounding--Sterile Preparations, Part 5: Verification of Accuracy, Sterility, and Sterilization of Compounded Preparations
Allen Loyd V Jr
, Okeke Claudia C
Jan/Feb 2008
Pg. 54-60

Diltiazem 5% in Lipoderm, Veterinary
Allen Loyd V Jr
Jan/Feb 2008
Pg. 67

Emetine Hydrochloride 30-mg/mL Injection
Allen Loyd V Jr
Jan/Feb 2008
Pg. 68

Flosulide 10-mg/mL Injection
Allen Loyd V Jr
Jan/Feb 2008
Pg. 69

Pentoxifylline 20-mg/mL Oral Suspension
Allen Loyd V Jr
Jan/Feb 2008
Pg. 70

Piroxicam 1% Soft-Patch Lipophilic Gel
Allen Loyd V Jr
Jan/Feb 2008
Pg. 71

Piroxicam 1% Soft-Patch Topical Gel
Allen Loyd V Jr
Jan/Feb 2008
Pg. 72

Trimethoprim 10-mg/mL Oral Suspension
Allen Loyd V Jr
Jan/Feb 2008
Pg. 73

Specialty Compounding for Improved Patient Care: 2006 National Survey of Compounding Pharmacists
Huffman DC
, Holmes Erin R
Jan/Feb 2008
Pg. 74-82

Room Temperature Stability of Injectable Succinylcholine Dichloride
Roy Julie J
, Boismenu Daniel, Mamer Orval A, Nguyen Bao T, Forest Jean-Marc, Hildgen Patrice
Jan/Feb 2008
Pg. 83-85

2007 Reviewers
Jan/Feb 2008
Pg. 86

PostScription: Consumer Options for Disposal of Unused Medications
Vail Jane
Jan/Feb 2008
Pg. 87

PreScription: Compounding Around the World
Allen Loyd V Jr
Mar/Apr 2008
Pg. 92

Current Compounding Practices in Europe
Carvalho Maria
, Tuleu Catherine, Taylor Kevin MG
Mar/Apr 2008
Pg. 94-99

Compounding Around the World
Vail Jane
Mar/Apr 2008
Pg. 102-115

Establishing a Quality-Assurance Program for Hospital Compounding
McElhiney Linda F
Mar/Apr 2008
Pg. 116-120

Hormone Therapy: It's Time for a Second Opinion
Collins Joseph J
, Ahlgrimm Maria
Mar/Apr 2008
Pg. 122-127

Newsletters: An Essential Marketing Tool
Storey Patricia L
Mar/Apr 2008
Pg. 128-129

Quality-Control Analytical Methods: Minimizing the Probability of Out-of-Specification Preparations: Results that Make You Say…Hmmm!
Odegard Russell D
Mar/Apr 2008
Pg. 130-135

Calculations
Stockton Shelly J
Mar/Apr 2008
Pg. 145

Acyclovir 5% Topical Ointment
Allen Loyd V Jr
Mar/Apr 2008
Pg. 146

Compatibility and Stability of Palonosetron Hydrochloride with Four Neuromuscular Blocking Agents During Simulated Y-Site Administration
Trusley Craig
, Ben Michel, Kupiec Thomas C, Trissel Lawrence A
Mar/Apr 2008
Pg. 156-160

Chemical Stability of Tramadol Hydrochloride Injection
Gupta Vishnu D
Mar/Apr 2008
Pg. 161-162

Pharmaceutical Development of Enteric-Release Hard Gelatin Capsules in the Compounding Setting
de Oliveira Ferreira Anderson
, Holandino Carla
Mar/Apr 2008
Pg. 163-169

PostScription: Accreditation by the Pharmacy Compounding Accreditation Board: Raising the Bar for Patient Care
Murry Tom
Mar/Apr 2008
Pg. 174-175

Basics of Compounding: Considerations for Implementing United States Pharmacopeia Chapter <797> Pharmaceutical Compounding--Sterile Preparations, Part 6: 2008 Revisions to Chapter <797>
Allen Loyd V Jr
, Okeke Claudia C
Mar/Apr 2008
Pg. 136-144

Alum 6.5% Topical Cream
Allen Loyd V Jr
Mar/Apr 2008
Pg. 147

Aminacrine Hydrochloride 0.1% Cream
Allen Loyd V Jr
Mar/Apr 2008
Pg. 148

Butesin Picrate 1% ointment
Allen Loyd V Jr
Mar/Apr 2008
Pg. 149

Carbamazepine Topical Preparations
Allen Loyd V Jr
Mar/Apr 2008
Pg. 150

Chlorhexidine Gel
Allen Loyd V Jr
Mar/Apr 2008
Pg. 151

EDTA 1% Cream
Allen Loyd V Jr
Mar/Apr 2008
Pg. 152

Erythromycin 1% and Neomycin Sulfate Ointment
Allen Loyd V Jr
Mar/Apr 2008
Pg. 153

Heparin Gel-Cream
Allen Loyd V Jr
Mar/Apr 2008
Pg. 154

Hydrogen Peroxide 8% Cream
Allen Loyd V Jr
Mar/Apr 2008
Pg. 155

Compatibility and Stability of Palonosetron Hydrochloride with Gentamicin, Metronidazole, or Vancomycin During Simulated Y-Site Administration
Kupiec Thomas C
, Ben Michel, Trusley Craig, Trissel Lawrence A
Mar/Apr 2008
Pg. 170-173

Basics of Compounding: Considerations for Implementing United States Pharmacopeia Chapter <797> Pharmaceutical Compounding--Sterile Preparations, Part 7: Microbial Contamination Risk Levels, 12-Hour Use, and Immediate Use
Allen Loyd V Jr
, Okeke Claudia C
May/Jun 2008
Pg. 252-257

Calculations
Stockton Shelly J
May/Jun 2008
Pg. 258

Standard Operating Procedure: Dealing with Patients Experiencing Pain: Presenting without a Prescription
Allen Loyd V Jr
May/Jun 2008
Pg. 259

African Scalp Lotion
Allen Loyd V Jr
May/Jun 2008
Pg. 260

Benzyl Benzoate Lotion
Allen Loyd V Jr
May/Jun 2008
Pg. 261

Calcium Gluconate 2.5% Topical Gel
Allen Loyd V Jr
May/Jun 2008
Pg. 262

Lubricating Gel
Allen Loyd V Jr
May/Jun 2008
Pg. 263

Meloxicam 0.3% Topical Gel
Allen Loyd V Jr
May/Jun 2008
Pg. 264

Miconazole Nitrate 2%, Deoxy-D-Glucose 0.2%, and Hydrocortisone 0.4% Lip Balm
Allen Loyd V Jr
May/Jun 2008
Pg. 265

Potassium Nitrate/Benzocaine/Tetracaine Dental Gel
Allen Loyd V Jr
May/Jun 2008
Pg. 266

Promethazine Hydrochloride 2.5-mg/mL Rectal Solution
Allen Loyd V Jr
May/Jun 2008
Pg. 267

Tolnaftate 1% Antifungal Microemulsion
Allen Loyd V Jr
May/Jun 2008
Pg. 268

Valsartan 4-mg/mL Oral Liquid
Allen Loyd V Jr
May/Jun 2008
Pg. 269

Chemical Stability of Naltrexone Hydrochloride Injection
Gupta Vishnu D
May/Jun 2008
Pg. 274-275

PostScription: A Contemporary Perspective on Compounding Education
Maine Lucinda L
May/Jun 2008
Pg. 279

Microbial Air-Sampling Equipment, Part 1: Meeting United States Pharmacopeia Chapter <797> Standards
Kastango Eric S
May/Jun 2008
Pg. 216-229

Communication with Pharmacy Technicians: How to Reduce Stress and Improve Pharmacy Operations
Fyke Jeremy P
, Hoffman Mary F
May/Jun 2008
Pg. 230-233

Obtaining Accreditation by the Pharmacy Compounding Accreditation Board, Part 3: Developing a Program of Quality Assurance and Continuous Quality Improvement
Cabaleiro Joe
May/Jun 2008
Pg. 234-236

PreScription: Pain!
Allen Loyd V Jr
May/Jun 2008
Pg. 180

Topical Treatment of Neuropathic Pain
Vadaurri Vince
May/Jun 2008
Pg. 182-190

Compounded Local Anesthetics to Minimize Pain from Medical Procedures
McElhiney Linda F
May/Jun 2008
Pg. 192-197

Dilution and Compounding of Ziconotide for Intrathecal Administration
Buchta Tony
, Fakata Keri, Stuart William
May/Jun 2008
Pg. 200-207

Pharmacy Compounding at the University of Connecticut: Secundum Artem et Scientia
Scagliarini Meghan
, Bogner Robin H
May/Jun 2008
Pg. 208-212

Developing and Implementing a Clinical Pharmacy Rotation in a Community Compounding Pharmacy
Walkup Kenny R
May/Jun 2008
Pg. 213-215

Litigating the Legality of Compounding: The Medical Center Pharmacy Case
Gibbs Jeffrey N
May/Jun 2008
Pg. 238-241

Developing a Niche Marketing Strategy
Storey Patricia L
May/Jun 2008
Pg. 242-243

Web 2.0 and Health 2.0: Are You In?
Felkey Bill G
May/Jun 2008
Pg. 244-246

A Process Verification Model for Quality Assurance in a Compounding Pharmacy
Zolner William J
May/Jun 2008
Pg. 247-251

Evaluation of the Percutaneous Absorption of Promethazine Hydrochloride, In Vitro, Using the Human Ex Vivo Skin Model
Bassani August S
, Banov Daniel, Lehman Paul A
May/Jun 2008
Pg. 270-273

Compatibility of Caspofungin Acetate Injection with Other Drugs During Simulated Y-Site Coadministration
Chan Pak
, Heatherly Kathy, Kupiec Thomas C, Trissel Lawrence A
May/Jun 2008
Pg. 276-278

PreScription: First Estriol, Then What?
Allen Loyd V Jr
Jul/Aug 2008
Pg. 284

Basics of Compounding: Considerations for Implementing United States Pharmacopeia Chapter <797> Pharmaceutical Compounding--Sterile Preparations, Part 8; Stability and Beyond-Use Dating
Allen Loyd V Jr
, Okeke Claudia C
Jul/Aug 2008
Pg. 344-353

Zirconium Oxide Lotion
Allen Loyd V Jr
Jul/Aug 2008
Pg. 364

Lack of Commercial Oral Drug Formulations for Children in Two Hospital Group Purchasing Agreements in France and Canada
Prot-Labarthe Sonia
, Bussieres Jean-Francois, Barett Pierre, Bourdon Olivier, Brion Francoise
Jul/Aug 2008
Pg. 365-367

Chemical Stability of Perphenazine in Two Commercially Available Vehicles for Oral Liquid Dosage Forms
Gupta Vishnu D
Jul/Aug 2008
Pg. 372-374

PostScription: It Is Not Just What You Say…But How You Say It!
Reed-Kane Dana
Jul/Aug 2008
Pg. 375

Estriol: Women's Choice vs. A Manufacturer's Greed
Goodrum Jennifer
Jul/Aug 2008
Pg. 286-292

Transdermal Progesterone: Effects on Menopausal Symptoms and on Thrombotic, Anticoagulant, and Inflammatory Factors in Postmenopausal Women
Stephenson Kenna
, Neuenschwander Pierre F, Kurdowska Anna K, Pinson Barbara, Price Carol
Jul/Aug 2008
Pg. 295-304

The Magic of Magnesium
Boomsma Diane
Jul/Aug 2008
Pg. 306-309

Progesterone and Traumatic Brain Injury: A Review of Literature
Williams LaVonn A
, Mead Jay H
Jul/Aug 2008
Pg. 310-315

Beyond-Use Dating, Labeling, Delivery, and Storage of Compounded and Repackaged Mediations in a Hospital or Institutional Setting
McElhiney Linda F
Jul/Aug 2008
Pg. 316-320

Microbial Air-Sampling Equipment, Part 2: Experiences of Compounding Pharmacists
Mixon Bill
, Cabaleiro Joe, Latta Kenneth S, Vail Jane
Jul/Aug 2008
Pg. 321-327

Recommendations for Overcoming Barriers to Medication Therapy Management Implementation, Part 1: Review of Literature
Fyke Jeremy P
, Yale Robert N, Corbett Corinne, Litera Natalie
Jul/Aug 2008
Pg. 329-333

Using Readily Available Technology to Start or Enhance Pharmacy-Based Immunization
Westrick Salisa C
, Felkey Bill G
Jul/Aug 2008
Pg. 334-337

Marketing for Your Community
Storey Patricia L
Jul/Aug 2008
Pg. 338-339

Quality-Control Analytical Methods: Homogeneity of Dosing Forms
Kupiec Thomas C
, Vu Nicole, Branscum David
Jul/Aug 2008
Pg. 340-343

Calculations
Stockton Shelly J
Jul/Aug 2008
Pg. 354

Chloroxylenol 1% and Chlorhexidine Diacetate 1% Topical Powder
Allen Loyd V Jr
Jul/Aug 2008
Pg. 355

Silicone Cream
Allen Loyd V Jr
Jul/Aug 2008
Pg. 356

Sodium Chloride 0.9% Ointment
Allen Loyd V Jr
Jul/Aug 2008
Pg. 357

Squalene 0.2% Cream
Allen Loyd V Jr
Jul/Aug 2008
Pg. 358

Sucralfate and Hyaluronic Acid Ointment
Allen Loyd V Jr
Jul/Aug 2008
Pg. 359

Tretinoin and (-)Alpha-Bisabolol Gel
Allen Loyd V Jr
Jul/Aug 2008
Pg. 360

Tretinoin and Dexpanthenol Gel
Allen Loyd V Jr
Jul/Aug 2008
Pg. 361

Ultrasonic Adhesive Gel
Allen Loyd V Jr
Jul/Aug 2008
Pg. 362

Vitamin A Suppository
Allen Loyd V Jr
Jul/Aug 2008
Pg. 363

Physical and Chemical Stability of Palonosetron Hydrochloride with Glycopyrrolate and Neostigmine During Simulated Y-Site Administration
Ben Michel
, Trusley Craig, Kupiec Thomas C, Trissel Lawrence A
Jul/Aug 2008
Pg. 368-371

PreScription: Compounding Around the World
Allen Loyd V Jr
Sep/Oct 2008
Pg. 382

Canine Public Servants: Caring for Drug Detection Dogs
Davidson Gigi S
Sep/Oct 2008
Pg. 384-390

Transdermal Amlodipine Besylate in Lipoderm for the Treatment of Feline Hypertension: A Report of Two Cases
Mixon William
, Helms Scott R
Sep/Oct 2008
Pg. 392-397

Veterinary Compounding for Myasthenia Gravis
Davidson Gigi S
Sep/Oct 2008
Pg. 398-401

Equine Anesthesia: Triple Drip
Davidson Gigi S
Sep/Oct 2008
Pg. 402-404

Publication Expansion of United States Pharmacopeial Convention's Veterinary Standards and Clinical Information
Neal Amy S
, DeVeau Ian, Schnatz Rick G
Sep/Oct 2008
Pg. 405-409

Golden Ticket to the United States Pharmacopeial Convention's Veterinary Internship
Kirk Loren Madden
Sep/Oct 2008
Pg. 410-413

Calculations
Stockton Shelly J
Sep/Oct 2008
Pg. 444-445

Aceclofenac 1.5% Gel-Cream
Allen Loyd V Jr
Sep/Oct 2008
Pg. 446

Testing the Long-Term Stability of Vancomycin Ophthalmic Solution
McLellan Christine
, Ngo Van, Pasedis Sophia, Dohlman Claes H
Sep/Oct 2008
Pg. 456-459

Compatibility and Stability of Palonosetron Hydrochloride with Lactated Ringer's, Hetastarch in Lactated Electrolyte, and Mannitol Injections During Simulated Y-Site Administration
Ben Michel
, Kupiec Thomas C, Trusley Craig, Trissel Lawrence A
Sep/Oct 2008
Pg. 460-462

Chemical Stability of Admixtures Combining Ziconotide with Fentanyl or Sufentanil During Simulated Intrathecal Administration
Shields David E
, Aclan Jennifer, Szatkowski Aaron
Sep/Oct 2008
Pg. 463-466

Medication Therapy Management Implementation, Part 2: Study Methodologies, Barriers, and Recommendations to Overcome Barriers
Fyke Jeremy P
, Yale Robert N, Corbett Corinne, Litera Natalie
Sep/Oct 2008
Pg. 414-418

Insurance for the Compounding Pharmacy Business, Part 1: Who Is Covered?
Baker Kenneth R
Sep/Oct 2008
Pg. 420-424

Excipient Choices for Special Populations
Nagel-Edwards Karen M
, Ko James Y
Sep/Oct 2008
Pg. 426-430

Obtaining Accreditation by the Pharmacy Compounding Accreditation Board, Part 4L Tips for "Last Minute" Preparations
Cabaleiro Joe
Sep/Oct 2008
Pg. 432-433

Technology for the Patient-Centric Pharmacy
Felkey Bill G
Sep/Oct 2008
Pg. 434-437

Acetaminophen 10-mg/mL Rectal Solution
Allen Loyd V Jr
Sep/Oct 2008
Pg. 447

Carnitine 400-mg/mL and Coenzyme Q10 10-mg/mL Solution
Allen Loyd V Jr
Sep/Oct 2008
Pg. 448

Marketing: Taking Your Show on the Road
Storey Patricia L
Sep/Oct 2008
Pg. 438-439

Basics of Compounding: Considerations for Implementing United States Pharmacopeia Chapter <797> Pharmaceutical Compounding--Sterile Preparations, Part 9: Immediate-Use Compounded Sterile Preparations
Allen Loyd V Jr
, Okeke Claudia C
Sep/Oct 2008
Pg. 440-443

Dichlorobenzyl Alcohol Tooth Gel
Allen Loyd V Jr
Sep/Oct 2008
Pg. 449

Estradiol 0.1% Vaginal Solution
Allen Loyd V Jr
Sep/Oct 2008
Pg. 450

Flurandrenolide Topical Film
Allen Loyd V Jr
Sep/Oct 2008
Pg. 451

Ketoprofen 20% Topical Solution
Allen Loyd V Jr
Sep/Oct 2008
Pg. 452

Lidocaine Adhesive System Gel
Allen Loyd V Jr
Sep/Oct 2008
Pg. 453

Piroxicam 5% and Dexpanthenol 5% Gel
Allen Loyd V Jr
Sep/Oct 2008
Pg. 454

Propafenone 1.5-mg/mL Oral Liquid
Allen Loyd V Jr
Sep/Oct 2008
Pg. 455

PostScription: The International Society of Pharmaceutical Compounding: A Discussion of Its Importance from the Perspective of ISPhC Leadership
Marro Diego
, Barbosa Carlos Mauricio
Sep/Oct 2008
Pg. 467

Prescription: Is "Globalization" a Good Idea?
Allen Loyd V Jr
Nov/Dec 2008
Pg. 474

Arthritis Epidemiology Impacts Pharmacists
Vance Dwight A
Nov/Dec 2008
Pg. 476-480

Compounding Challenges for Immunocompromised Patients
McElhiney Linda F
Nov/Dec 2008
Pg. 482-487

Case Reports: Compounding to Relieve Arthritis Pain
Marshall Robert
, Vidaurri Vincent A, Boomsma Diane, Buchta Anthony J, Vail Jane
Nov/Dec 2008
Pg. 498-504

Symbols: Historic and Current Uses
Bailey Emilee
Nov/Dec 2008
Pg. 505-507

Medication Therapy Management Implementation, Part 3: Barriers and Recommendations to Overcome Barriers
Fyke Jeremy P
, Yale Robert N, Corbett Corinne, Litera Natalie
Nov/Dec 2008
Pg. 508-513

Quality-Control Analytical Methods: Overview of Beyond-Use Dating for Compounded Sterile Preparations
Trissel Lawrence A
Nov/Dec 2008
Pg. 524-528

Calculations
Stockton Shelly J
Nov/Dec 2008
Pg. 539

Glycerin, Sterile
Allen Loyd V Jr
Nov/Dec 2008
Pg. 542

Indomethacin 2% in Pluronic Lecithin Organogel
Allen Loyd V Jr
Nov/Dec 2008
Pg. 543

Ketorolac Tromethamine 2% Topical Gel
Allen Loyd V Jr
Nov/Dec 2008
Pg. 544

Liothyronine Sodium (T3) 5-mcg/0.1-mL Transdermal Cream
Allen Loyd V Jr
Nov/Dec 2008
Pg. 546

Differentiation and Treatment of Hypothyroidism, Functional Hypothyroidism, and Functional Metabolism
Paoletti Jim
Nov/Dec 2008
Pg. 488-497

Insurance for the Compounding Pharmacy Business, Part 2: What, When, and Where
Baker Kenneth R
Nov/Dec 2008
Pg. 514-523

Branding: Give Your Small Business a Big Image
Storey Patricia L
Nov/Dec 2008
Pg. 537-538

Cyclobenzaprine Hydrochloride 0.5% and Diclofenac Sodium 3% in Pluronic Lecithin Organogel
Allen Loyd V Jr
Nov/Dec 2008
Pg. 540

Cyclobenzaprine Hydrochloride 1%, Dextromethorphan Hydrobromide 10%, Guaifenesin 10%, and Indomethacin 20% Penetrating Gel
Allen Loyd V Jr
Nov/Dec 2008
Pg. 541

Liothyronine Sodium (T3) 5-mcg/Hydrocortisone 5-mg Slow-Release Capsules
Allen Loyd V Jr
Nov/Dec 2008
Pg. 545

Liothyronine Sodium (T3) 5-mcg/Selenium 100-mcg Slow-Release Capsules
Allen Loyd V Jr
Nov/Dec 2008
Pg. 547

Liothyronine Sodium (T3) 5-mcg Slow-Release Capsules
Allen Loyd V Jr
Nov/Dec 2008
Pg. 548

Morphine Sulfate 20-mg and Prochlorperazine Maleate 10-mg Troches
Allen Loyd V Jr
Nov/Dec 2008
Pg. 549

Physical Compatibility and Chemical Stability of a Concentrated Solution of Atropine Sulfate (2 mg/mL) for Use as an Antidote in Nerve Agent Casualties
Donnelly Ronald F
, Corman Celine
Nov/Dec 2008
Pg. 550-552

Chemical Stability of Admixtures Containing Ziconotide 25 mcg/mL and Morphine Sulfate 10 mg/mL or 20 mg/mL During Simulated Intrathecal Administration
Shields David E
, Aclan Jennifer, Szatkowski Aaron
Nov/Dec 2008
Pg. 553-557

PostScription: Supporting Compounding Around the World
Allen Loyd V Jr
Nov/Dec 2008
Pg. 565

Basics of Compounding: United States Pharmacopeia General Chapter <797> Pharmaceutical Compounding--Sterile Preparations, Part 10: First Revision: The Main Changes, Events, and Rationale
Okeke Claudia C
, Newton David W, Kastango Eric S, Allen Loyd V Jr
Nov/Dec 2008
Pg. 530-536

Stability of Metronidazole Benzoate in SyrSpend SF One-Step Suspension System
Vu Nicole T
, Aloumanis Vasileios, Ben Michel J, Kupiec Thomas C, Patterson Evelyn K, Radke Joshua, Erickson Martin A III, Schneider Gary
Nov/Dec 2008
Pg. 558-564

Return to Top